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Abstract
The functional consequences of trait associated SNPs are often investigated using expres-
sion quantitative trait locus (eQTL) mapping. While trait-associated variants may operate in
a cell-type specific manner, eQTL datasets for such cell-types may not always be available.
We performed a genome-environment interaction (GxE) meta-analysis on data from 5,683
samples to infer the cell type specificity of whole blood cis-eQTLs. We demonstrate that this
method is able to predict neutrophil and lymphocyte specific cis-eQTLs and replicate these
predictions in independent cell-type specific datasets. Finally, we show that SNPs associat-
ed with Crohn’s disease preferentially affect gene expression within neutrophils, including
the archetypal NOD2 locus.
Author Summary
Many variants in the genome, including variants associated with disease, affect the expres-
sion of genes. These so-called expression quantitative trait loci (eQTL) can be used to gain
insight in the downstream consequences of disease. While it has been shown that many
disease-associated variants alter gene expression in a cell-type dependent manner, eQTL
datasets for specific cell types may not always be available and their sample size is often
limited. We present a method that is able to detect cell type specific effects within eQTL
datasets that have been generated from whole tissues (which may be composed of many
cell types), in our case whole blood. By combining numerous whole blood datasets through
meta-analysis, we show that we are able to detect eQTL effects that are specific for neutro-
phils and lymphocytes (two blood cell types). Additionally, we show that the variants asso-
ciated with some diseases may preferentially alter the gene expression in one of these cell
types. We conclude that our method is an alternative method to detect cell type specific
eQTL effects, that may complement generating cell type specific eQTL datasets and that
may be applied on other cell types and tissues as well.
eQTL Cell-Type Interaction in Whole Blood
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Introduction
In the past seven years, genome-wide association studies (GWAS) have identified thousands of
genetic variants that are associated with human disease [1]. The realization that many of the
disease-predisposing variants are non-coding and that single nucleotide polymorphisms
(SNPs) often affect the expression of nearby genes (i.e. cis-expression quantitative trait loci; cis-
eQTLs) [2] suggests these variants have a predominantly regulatory function. Recent studies
have shown that disease-predisposing variants in humans often exert their regulatory effect on
gene expression in a cell-type dependent manner [3–5]. However, most human eQTL studies
have used sample data obtained from mixtures of cell types (e.g. whole blood) or a few specific
cell types (e.g. lymphoblastoid cell lines) due to the prohibitive costs and labor required to puri-
fy subsets of cells from large samples (by cell sorting or laser capture micro-dissection). In ad-
dition, the method of cell isolation can trigger uncontrolled processes in the cell, which can
cause biases. In consequence, it has been difficult to identify in which cell types most disease-
associated variants exert their effect.
Here we describe a generic approach that uses eQTL data in mixtures of cell types to infer
cell-type specific eQTLs (Fig 1). Our strategy includes: (i) collecting gene expression data from
an entire tissue; (ii) predicting the abundance of its constituent cell types (i.e. the cell counts),
by using expression levels of genes that serve as proxies for these different cell types (since not
all datasets might have actual constituent cell count measurements). We used an approach sim-
ilar to existing expression and methylation deconvolution methods [6–11]; (iii) run an associa-
tion analysis with a term for interaction between the SNP and the proxy for cell count to detect
cell-type-mediated or-specific associations, and (iv) test whether known disease associations
are enriched for SNPs that show the cell-type-mediated or-specific effects on gene expression
(i.e. eQTLs).
Results
We applied this strategy to 5,863 unrelated, whole blood samples from seven cohorts: EGCUT
[12], InCHIANTI [13], Rotterdam Study [14], Fehrmann [2], SHIP-TREND [15], KORA F4
[16], and DILGOM [17]. Blood contains many different cell types that originate from either
the myeloid (e.g. neutrophils and monocytes) or lymphoid lineage (e.g. B-cells and T-cells).
Even though neutrophils comprise ~60% [18,19] of all white blood cells, no neutrophil eQTL
data have been published to date, because this cell type is particularly difficult to purify or cul-
ture in the lab [20].
For the purpose of illustrating our cell-type specific analysis strategy in the seven whole
blood cohorts, we focused on neutrophils. Direct neutrophil cell counts and percentages were
only available in the EGCUT and SHIP-TREND cohorts, requiring us to infer neutrophil per-
centages for the other five cohorts. We used the EGCUT cohort as a training dataset to identify
a list of 58 Illumina HT12v3 probes that correlated positively with neutrophil percentage
(Spearman’s correlation coefficient R> 0.57; S1 Fig, S1 Table). We observed that 95% of these
genes show much higher expression in purified neutrophils, as compared to 13 other purified
blood cell-types, based on RNA-seq data from the BLUEPRINT epigenome project [21] (S2
Fig). We then summarized the gene expression levels of these 58 individual probes into a single
neutrophil percentage estimate, by applying principal component analysis (PCA) and deter-
mining the first principal component (PC). We then used this first PC as a proxy for neutrophil
percentage, an approach that is similar to existing expression and methylation deconvolution
methods [6–11]. In the EGCUT dataset, the actual neutrophil percentage showed some correla-
tion with age (Pearson R = 0.08, P = 0.02), but no association with gender (Student's T-test
P = 0.31; S3 Fig) in the EGCUT dataset. The proxy for neutrophil percentage showed the same
eQTL Cell-Type Interaction in Whole Blood
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behavior: some correlation with age (Pearson R = 0.14, P = 6 x 10–5) and no association with
gender (P = 0.11). This predicted neutrophil percentage strongly correlated with the actual
neutrophil percentage (Spearman R = 0.75, Pearson R = 0.76; Fig 2). Including more or fewer
top probes than the top 58 probes resulted in similar correlations (S4 Fig). We then used this
set of 58 probes in each of the other cohorts as well, and used PCA per cohort on the probe cor-
relation matrix of these 58 probes. In the SHIP-TREND cohort, for which the actual neutrophil
percentage was available as well, we observed that the inferred neutrophil proxy strongly corre-
lated with the actual neutrophil percentage (Spearman R = 0.81, Pearson R = 0.82; Fig 2).
Here we limited our analysis to 13,124 cis-eQTLs that were previously discovered in a whole
blood eQTL meta-analysis of a comparable sample size [22] (we note that these 13,124 cis-
eQTLs were detected while assuming a generic effect across cell-types, and as such, genome-
wide application of cell-type specificity strategy might result in the detection of additional cell-
type-specific cis-eQTLs). To infer the cell-type specificity of each of these eQTLs, we performed
the eQTL association analysis with a term for interaction between the SNP marker and the
proxy for cell count within each cohort, followed by a meta-analysis of the interaction term
(weighted for sample size) across all the cohorts. We identified 1,117 cis-eQTLs with a signifi-
cant interaction effect (8.5% of all cis-eQTLs tested; false discovery rate (FDR)< 0.05; 1,037
unique SNPs and 836 unique probes; S2 Table and S3 Table). The power to detect these effects
depends on the original cis-eQTL effect size, as we observed that the main effect of cis-eQTLs
that have a significant interaction term generally explained more variance in gene expression
in the previously published cis-eQTL meta-analysis [22], as compared to the cis-eQTLs that
did not show a significant interaction: 71% of the cell-type specific eQTLs had a main effect
that explained at least 3% of the total expression variation, whereas 25% of the cis-eQTLs that
did not show a show significant interaction explained at least 3% of the total expression varia-
tion (S5 Fig). Out of the total number of cis-eQTLs tested, 909 (6.9%) had a positive direction
of effect, which indicates that these cis-eQTLs show stronger effect sizes when more neutro-
phils are present (i.e. ‘neutrophil-mediated cis-eQTLs’; 843 unique SNPs and 692 unique
probes). Another 208 (1.6%) had a negative direction of effect (196 unique SNPs and 145
unique probes), indicating a stronger cis-eQTL effect size when more lymphoid cells are pres-
ent (i.e. ‘lymphocyte-mediated cis-eQTLs’; since lymphocyte percentages are strongly negative-
ly correlated with neutrophil percentages; Fig 1). Overall, the directions of the significant
interaction effects were consistent across the different cohorts, indicating that our findings are
robust (S6 Fig).
We validated the neutrophil- and lymphoid-mediated cis-eQTLs in six small, but purified
cell-type gene expression datasets that had not been used in our meta-analysis. We generated
new eQTL data from two lymphoid cell types (CD4+ and CD8+ T-cells) and one myeloid cell
type (neutrophils, see online methods) and used previously generated eQTL data on two lym-
phoid cell types (lymphoblastoid cell lines and B-cells) and another myeloid cell type (mono-
cytes, S4 Table). As expected, compared to cis-eQTLs without a significant interaction term
(‘generic cis-eQTLs’, n = 12,007) the 909 neutrophil-mediated cis-eQTLs did indeed show very
strong cis-eQTL effects in the neutrophil dataset (Wilcoxon P = 2.5 x 10–81 when compared to
generic cis-eQTLs; Fig 3A). We observed that these cis-eQTLs also showed an increased effect-
size in the monocyte dataset (Wilcoxon P-value = 4.9 x 10–31 when compared to generic cis-
eQTLs; Fig 3A). Because both neutrophils and monocytes are myeloid lineage cells, this sug-
gests that some of the neutrophil-mediated cis-eQTL effects also show stronger effects in other
cells of the myeloid lineage. Conversely, the 208 lymphoid-mediated cis-eQTLs had a pro-
nounced effect in each of the lymphoid datasets (Wilcoxon P-value 7.8 x 10–14 compared to
generic cis-eQTLs; Fig 3A), while having small effect sizes in the myeloid datasets. These vali-
dation results indicate that our method is able to reliably predict whether a cis-eQTL is
eQTL Cell-Type Interaction in Whole Blood
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mediated by a specific cell type. Unfortunately, the cell type that mediates the cis-eQTL is not
necessarily the one in which the cis-gene has the highest expression (Fig 3B), making it impos-
sible to identify cell-type-specific eQTLs directly on the basis of expression levels.
Myeloid and lymphoid blood cell types provide crucial immunological functions. Therefore,
we assessed five immune-related diseases for which genome-wide association studies previous-
ly identified at least 20 loci with a cis-eQTL in our meta-analysis. We observed a significant en-
richment only for Crohn’s disease (CD), (binomial test, one-tailed P = 0.002, S5 Table): out of
49 unique CD-associated SNPs showing a cis-eQTL effect, 11 (22%) were neutrophil-mediated.
These 11 SNPs affect the expression of 14 unique genes (ordered by size of interaction effect:
IL18RAP, CPEB4, RP11-514O12.4, RNASET2, NOD2, CISD1, LGALS9, AC034220.3, SLC22A4,
HOTAIRM2, ZGPAT, LIME1, SLC2A4RG, and PLCL1). CD is a chronic inflammatory disease
of the intestinal tract. While impaired T-cell responses and defects in antigen presenting cells
have been implicated in the pathogenesis of CD, so far little attention has been paid to the role
Fig 1. Method overview. I) Starting with a dataset that has cell count measurements, determine a set of probes that have a strong positive correlation to the
cell count measurements. Calculate the correlation between these specific probes in the other datasets, and apply principal component analysis to combine
them into a single proxy for the cell count measurement. II) Apply the prediction to other datasets lacking cell count measurements. III) Use the proxy as a
covariate in a linear model with an interaction term in order to distinguish cell-type-mediated from non-cell-type-mediated eQTL effects.
doi:10.1371/journal.pgen.1005223.g001
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of neutrophils, because its role in the development and maintenance of intestinal inflammation
is controversial: homeostatic regulation of the intestine is complex and both a depletion and an
increase in neutrophils in the intestinal submucosal space can lead to inflammation. On the
one hand, neutrophils are essential in killing microbes that translocate through the mucosal
layer. The mucosal layer is affected in CD, but also in monogenic diseases with neutropenia
and defects in phagocyte bacterial killing, such as chronic granulomatous disease, glycogen
storage disease type I, and congenital neutropenia, leading to various CD phenotypes [23]. On
the other hand, an increase in activated neutrophils that secrete pro-inflammatory chemokines
and cytokines (including IL18RAP which has a neutrophil specific eQTL) maintains inflamma-
tory responses. Pharmacological interventions for the treatment of CD have been developed to
specifically target neutrophils and IL18RAP, including Sagramostim [24] and Natalizumab
[25]. These results show clear neutrophil-mediated eQTL effects for various known CD genes,
including the archetypal NOD2 gene. Although CD has previously been shown to have a slight-
ly higher incidence in females [26,27], we did not find any relationship between NOD2 expres-
sion and gender or age (Student's T-test P = 0.08 and Pearson's correlation P = 0.39
respectively; S7 Fig). As such, our results provide deeper insight into the role of neutrophils in
CD pathogenesis.
Large sample sizes are essential in order to find cell-type-mediated cis-eQTLs (Fig 4): when
we repeat our study on fewer samples (ascertained by systematically excluding more cohorts
from our study), the number of significant cell-type-mediated eQTLs decreased rapidly. This
was particularly important for the lymphoid-mediated cis-eQTLs, because myeloid cells are ap-
proximately twice as abundant as lymphoid cells in whole blood. Consequently, detecting lym-
phoid-mediated cis-eQTLs is more challenging than detecting neutrophil-specific cis-eQTLs.
As whole blood eQTL data is easily collected, we were able to gather a sufficient sample size in
order to detect cell-type-mediated or-specific associations without requiring the actual purifi-
cation of cell types.
Fig 2. Validation of neutrophil proxy. There is a strong correlation between the neutrophil proxy and the actual neutrophil percentage measurements in the
training dataset (EGCUT, Spearman R = 0.75). Validation of neutrophil prediction in the SHIP-TREND cohort shows a strong correlation (Spearman
R = 0.81) between the neutrophil proxy and actual neutrophil percentage measurements in this dataset.
doi:10.1371/journal.pgen.1005223.g002
eQTL Cell-Type Interaction in Whole Blood
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Fig 3. Validation of neutrophil and lymphoid specific cis-eQTLs in purified cell type eQTL datasets. A) We validated the neutrophil- and lymphoid-
mediated cis-eQTL effects in four purified cell type datasets from the lymphoid lineage (B-cells, CD4+ T-cells, CD8+ T-cells and lymphoblastoid cell lines)
and in two datasets from the myeloid lineage (monocytes and neutrophils). Compared to generic cis-eQTLs, large effect sizes were observed for neutrophil-
mediated cis-eQTLs in myeloid lineage cell types, and small effect sizes in the lymphoid datasets. Conversely, lymphoid-mediated cis-eQTL effects had
large effect sizes specifically in the lymphoid lineage datasets, while having smaller effect sizes in myeloid lineage datasets. These results indicate that our
method is able to reliably predict whether a specific cis-eQTL is mediated by cell type. B) Comparison between average gene expression levels between
different purified cell type eQTL datasets shows that neutrophil mediated cis-eQTLs have, on average a lower expression in cell types derived from the
lymphoid lineage, and a high expression in myeloid cell types, while the opposite is true for lymphocyte mediated cis-eQTLs.
doi:10.1371/journal.pgen.1005223.g003
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Discussion
Here we have shown that it is possible to infer in which blood cell-types cis-eQTLs are operat-
ing from a whole blood dataset. Cell-type proportions were predicted and subsequently used in
a G x E interaction model. Hundreds of cis-eQTLs showed stronger effects in myeloid than
lymphoid cell-types and vice versa.
These results were replicated in 6 individual purified cell-type eQTL datasets (two reflecting
the myeloid and four reflecting the lymphoid lineage). This indicates our G x E analysis pro-
vides important additional biological insights for many SNPs that have previously been found
to be associated with complex (molecular) traits.
Here, we concentrated on identifying cis-eQTLs that are preferentially operating in either
myeloid or lymphoid cell-types. We did not attempt to assess this for specialized cell-types
within the myeloid or lymphoid lineage. However, this is possible if cell-counts are available
for these cell-types, or if these cell-counts can be predicted by using a proxy for those cell-
counts. As such, identification of cell-type mediated eQTLs for previously unstudied cell-types
is possible, without the need to generate new data. However, it should be noted that these indi-
vidual cell-types typically have a rather low abundance within whole blood (e.g. natural killer
cells only comprise ~2% of all circulating white blood cells). As a consequence, in order to have
sufficient statistical power to identify eQTLs that are mediated by these cell-types, very large
whole blood eQTL sample-sizes are required and the cell type of interest should vary in abun-
dance between individuals (analogous to the difference in the number of identified lymphoid
Fig 4. Effect of sample size on power to detect cell type specific cis-eQTLs.We systematically excluded
datasets from our meta-analysis in order to determine the effect of sample size on our ability to detect
significant interaction effects. The number of significant interaction effects was rapidly reduced when the
sample size was decreased (the number of unique significant probes given a Bonferroni corrected P-
value < 8.1 x 10–6 is shown). In general, due to their low abundance in whole blood, lymphoid-mediated cis-
eQTL effects are harder to detect than neutrophil-mediated cis-eQTL effects.
doi:10.1371/journal.pgen.1005223.g004
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mediated cis-eQTLs, as compared to the number of neutrophil mediated cis-eQTLs, which is
likely caused by their difference in abundance in whole blood). For instance we have recently
investigated whole peripheral blood RNA-seq data in over 2,000 samples and identified only a
handful monocyte specific eQTLs (manuscript in preparation). As such this indicates that in
order to identify monocyte specific eQTLs using whole blood, thousands of samples should
be studied.
We confined our analyses to a subset of cis-eQTLs for which we had previously identified a
main effect in whole peripheral blood [22]: for each cis-eQTL gene, we only studied the most
significantly associated SNP. Considering that for many cis-eQTLs multiple, unlinked SNPs
exist that independently affect the gene expression levels, it is possible that we have missed my-
eloid or lymphoid mediation of these secondary cis-EQTLs.
The method we have applied to predict the neutrophil percentage in the seven whole blood
datasets involves correlation of gene expression probes to cell count abundances and subse-
quent combination of gene expression probes into a single predictor using PCA. This approach
is comparable to other deconvolution methods for methylation and gene expression data [6–
11]. However, methods have also been published [28,29] that take a more agnostic approach
towards identifying different cell-types and their abundances across different individuals. The
Preininger et almethod [28] identified different axes of gene expression variation in peripheral
blood, of which some reflect proxies of certain cell-types. We quantified these axes for each of
the samples of the EGCUT and Fehrmann cohorts by creating proxy phenotypes, and subse-
quently conducted per axis an interaction meta-analysis and indeed identified eQTLs that were
significantly mediated by these axes (S6 Table). We first ascertained the Z-scores of the eQTL
interaction effects for axis 5 of Preininger et al, an axis that is known to correlate strongly with
neutrophil percentage. As expected, we observed a very strong correlation with the Z-scores of
the eQTL interaction effects for the neutrophil proxy (R = 0.72). While some other axes also
mediate eQTLs that might be attributable to differences in other cell-type proportions (e.g. axis
2 that is likely due to differences in reticulocyte proportions), while other axes might even re-
flect differences in the state in which these cells are (e.g. stimulated immune cells or senescent
cells). We believe it is possible that some of these axes might reflect differences in gene activity
(rather than differences in cell-type proportions), and that it could be that such differences in
gene activity might mediate certain eQTLs. This indicates that by applying novel methods that
can summarize gene expression [28,29] and using these summaries as interaction terms when
conducting eQTL mapping, various ‘context specific’ eQTLs might become detectable. Al-
though we have shown that the proxy that is created by our method is able to predict neutro-
phil percentage accurately, this may not be the case for all cell types available in whole blood,
which may be greatly dependent upon the ability of individual gene expression probes to differ-
entiate between cell types
However, we anticipate that the (pending) availability of large RNA-seq based eQTL data-
sets, statistical power to identify cell-type mediated eQTLs using our approach will improve:
since RNA-seq enables very accurate gene expression level quantification and is not limited to
a set of preselected probes that interrogate well known genes (as is the case for microarrays),
the detection of genes that can serve as reliable proxies for individual cell-types will improve.
Using RNA-seq data, it is also possible to assess whether SNPs that affect the expression of
non-coding transcripts, affect splicing [30] or result in alternative polyadenylation [31] are me-
diated by specific cell-types.
The method we have used did not account for heteroscedasticity while estimating the stan-
dard errors of the interaction term, which may lead to inflated statistics. We therefore com-
pared the standard errors that we used, with standard errors that have been estimated while
accounting for heteroscedasticity (using the R-package 'sandwich'). The heteroscedasticity-
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consistent standard errors and p-values were very similar (Pearson correlation> 0.95; S8 Fig)
to the standard errors that did not account for heteroscedasticity. We also note that measure-
ment error in the covariates of the model we have used may cause the inferred betas to be bi-
ased. Structural equation modeling may be used to determine unbiased estimates by taking
measurement errors of the covariates into account (particularly the neutrophil percentage
proxy). However, typically these methods require replicate measurements of the covariates,
which were not available for the cohorts in our study. As such, the observed interaction effects
may be either underestimated or overestimated, depending on the character and the degree of
the measurement error in our covariates.
Although we applied our method to whole blood gene expression data, our method can be
applied to any tissue, alleviating the need to sort cells or to perform laser capture micro dissec-
tion. The only prerequisite for our method is the availability of a relatively small training data-
set with cell count measurements in order to develop a reliable proxy for cell count
measurements. Since the number of such training datasets is rapidly increasing and meta-anal-
yses have proven successful [2,22], our approach provides a cost-effective way to identify cell-
type-mediated or-specific associations that can supplement results obtained from purified cell
type specific datasets, and it is likely to reveal major biological insights.
Materials and Methods
Setup of study
This eQTL meta-analysis is based on gene expression intensities measured in whole blood sam-
ples. RNA was isolated with either PAXgene Tubes (Becton Dickinson and Co., Franklin
Lakes, NJ, USA) or Tempus Tubes (Life Technologies). To measure gene expression levels, Illu-
mina Whole-Genome Expression Beadchips were used (HT12-v3 and HT12-v4 arrays, Illu-
mina Inc., San Diego, USA). Although different identifiers are used across these different
platforms, many probe sequences are identical. Meta-analysis could thus be performed if
probe-sequences were equal across platforms. Integration of these probe sequences was per-
formed as described before [22]. Genotypes were harmonized using HapMap2-based imputa-
tion using the Central European population [32]. In total, the eQTL genotype x environment
interaction meta-analysis was performed on seven independent cohorts, comprising a total of
5,863 unrelated individuals (full descriptions of these cohorts can be found in the Supplemen-
tary Note). Mix-ups between gene expression samples and genotype samples were corrected
usingMixupMapper [33].
Gene expression normalization for interaction analysis
Each cohort performed gene expression normalization individually: gene expression data was
quantile normalized to the median distribution then log2 transformed. The probe and sample
means were centered to zero. Gene expression data was then corrected for possible population
structure by removing four multi-dimensional scaling components (MDS components ob-
tained from the genotype data using PLINK) using linear regression. Additionally, we corrected
for possible confounding factors due to arrays of poor RNA quality. We reasoned that arrays of
poor RNA quality generally show expression for genes that are normally lowly expressed with-
in the tissue (e.g. expression for brain genes in whole blood data). As such, the expression pro-
files for such arrays will deviate overall from arrays with proper RNA quality. To capture such
variable arrays, we calculated the first PC from the sample correlation matrix and correlated
the first PC with the sample gene expression measurements. Samples with a correlation< 0.9
were removed from further analysis (S9 Fig).
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In order to improve statistical power to detect cell-type mediated eQTLs, we corrected the
gene expression for technical and batch effects (here we applied principal component analysis
and removed per cohort the 40 strongest principal components that affect gene expression).
Such procedures are commonly used when conducting cis-eQTL mapping [2,5,22,30,31,34].
To minimize the amount of genetic variation removed by this procedure, we performed QTL
mapping for each principal component, to ascertain whether genetic variants could be detected
that affected the PC. If such an effect was detected, we did not correct the gene expression data
for that particular PC [22]. As a result, this procedure also removed the majority of the varia-
tion that explained the correlation between neutrophil percentage and gene expression (S10
Fig), minimizing issues with possible collinearity when testing the interaction effects. We chose
to remove 40 PCs based on our previous study results, which suggested that this was the opti-
mum for detecting eQTLs [22]. We would like to stress that while PC-corrected gene expres-
sion data was then used as the outcome variable in our gene x environment interaction model,
we used gene expression data that was not corrected for PCs to initially create the neutrophil
cell percentage proxy.
Creating a proxy for neutrophil cell percentage from quantile normalized
and log2 transformed gene expression data
To be able to determine whether a cis-eQTL is mediated by neutrophils, we reasoned that such
a cis-eQTL would show a larger effect size in individuals with a higher percentage of neutro-
phils than in individuals with a lower percentage. However, this required the percentage of
neutrophils in whole blood to be known, and cell-type percentage measurements were not
available for all of the cohorts. We therefore created a proxy phenotype that reflected the actual
neutrophil percentage that would also be applicable to datasets without neutrophil percentage
measurements. In the EGCUT dataset, we first quantile normalized and log2 transformed the
raw expression data. We then correlated the gene expression levels of individual probes with
the neutrophil percentage, and selected 58 gene expression probes showing a high positive cor-
relation (Spearman R> 0.57). Here, we chose to use the quantile normalized, log2 transformed
gene expression data that was not corrected for principal components, since correction for
principal components would remove the correlation structure between gene expression and
neutrophil percentage (S10 Fig).
In each independent cohort, we corrected for possible confounding factors due to arrays
with poor RNA quality, by correlating the quantile normalized and log2 transformed gene ex-
pression measurements against the first PC determined from the sample correlation matrix.
Only samples with a high correlation (r 0.9) were included in further analyses. Then, for
each cohort, we calculated a correlation matrix for the neutrophil proxy probes (the probes se-
lected from the EGCUT cohort). The gene expression data used was quantile normalized, log2
transformed and corrected for MDS components. Applying PCA to the correlation matrix, we
then obtained PCs that described the variation among the probes selected from the EGCUT co-
hort. As the first PC (PC1) contributes the largest amount of variation, we considered PC1 as a
proxy-phenotype for the cell type percentages.
Determining cell-type mediation using an interaction model
Considering the overlap between the cohorts in this study and our previous study, we limited
our analysis to the 13,124 cis-eQTLs having a significant effect (false discovery rate,
FDR< 0.05) in our previous study [22]. This included 8,228 unique Illumina HT12v3 probes
and 10,260 unique SNPs (7,674 SNPs that showed the strongest effect per probe, and 2,586
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SNPs previously associated with complex traits and diseases, as reported in the Catalog of Pub-
lished Genome-Wide Association Studies [1], on 23rd September, 2013).
We defined the model for single marker cis-eQTL mapping as follows:
Y  Iþ 1 Gþ e
where Y is the gene expression of the gene, β1 is the slope of the linear model, G is the geno-
type, I is the intercept with the y-axis, and e is the general error term for any residual variation
not explained by the rest of the model.
We then extended the typical linear model for single marker cis-eQTL mapping to include a
covariate as an independent variable, and captured the interaction between the genotype and
the covariate using an interaction term:
Y  Iþ 1 Gþ 2 Pþ 3 P:Gþ e
where P (cell-type proxy) is the covariate, and P:G is the interaction term between the covariate
and the genotype. We used gene expression data corrected for 40 PCs as the predicted variable
(Y). The interaction terms were then meta-analyzed over all cohorts using a Z-score method,
weighted for the sample size [35].
Multiple testing correction
Since the gene-expression data has a correlated structure (i.e. co-expressed genes) and the ge-
notype data also has a correlated structure (i.e. linkage disequilibrium between SNPs), a Bon-
ferroni correction would be overly stringent. We therefore first estimated the effective number
of uncorrelated tests by using permuted eQTL results from our previous cis-eQTL meta-analy-
sis [22]. The most significant P-value in these permutations was 8.15 x 10–5, when averaged
over all permutations. As such, the number of effective tests = 0.5 / 8.15 x 10–5 6134, which
is approximately half the number of correlated cis-eQTL tests that we conducted (= 13,124).
Next, we controlled the FDR at 0.05 for the interaction analysis: for a given P-value threshold
in our interaction analysis, we calculated the number of expected results (given the number of
effective tests and a uniform distribution) and determined the observed number of eQTLs that
were below the given P-value threshold (FDR = number of expected p-values below threshold /
number of observed p-values below threshold). At an FDR of 0.05, our nominal p-value thresh-
old was 0.009 (corresponding to an absolute interaction effect Z-score of 2.61).
Cell-type specific cis-eQTLs and disease
For each trait in the GWAS catalog, we pruned all SNPs with a GWAS association P-value
below 5 x 10–8, using an r2 threshold of 0.2. We only considered traits that had more than 20
significant eQTL SNPs after pruning (irrespective of cell-type mediation). Then, we deter-
mined the proportion of pruned neutrophil-mediated cis-eQTLs for the trait relative to all the
neutrophil-mediated cis-eQTLs. The difference between both proportions was then tested
using a binomial test.
Data access
The source code and documentation for this type of analysis are available as part of the eQTL
meta-analysis pipeline at https://github.com/molgenis/systemsgenetics
Summary results are available from http://www.genenetwork.nl/celltype
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Accession numbers
Discovery cohorts: Fehrmann (GSE 20142), SHIP-TREND (GSE 36382), Rotterdam Study
(GSE 33828), EGCUT (GSE 48348), DILGOM (E-TABM-1036), InCHIANTI (GSE 48152),
KORA F4 (E-MTAB-1708). Replication Cohorts: Stranger (E-MTAB-264), Oxford (E-MTAB-
945).
Supporting Information
S1 Fig. Neutrophil percentage and gene expression correlation distribution in EGCUT. In
order to predict the neutrophil percentage, we selected 58 gene expression probes (0.1% of the
dataset) that strongly positively correlated with neutrophil percentage in the EGCUT dataset
(Spearman R> 0.57, P< 3 x 10–72, n = 825).
(TIF)
S2 Fig. Comparison of expression in the BLUEPRINT study. The 58 probes we used to esti-
mate neutrophil percentage map to 44 unique genes. We compared the gene expression levels
for these genes using RNA-seq data from the BLUEPRINT consortium among 14 different cell
types. For most of these cell-types multiple biological replicates have been assayed. We quantile
normalized, log2 transformed and then centered the expression levels for every individual gene
to a mean of zero and a standard deviation of one. We observed that 42 of these 44 genes show
significantly higher expression (Student's T-test P< 0.001), as compared to the other 13 cell
types. NS: non significant.
(TIF)
S3 Fig. Relationship between neutrophil percentage, age and gender.We correlated the ac-
tual neutrophil percentage (top) and the inferred neutrophil percentage (bottom) with age in
the EGCUT dataset (n = 825) and observed that there is a low, but significant correlation be-
tween age and neutrophil percentage. However, neutrophil percentage is not significantly asso-
ciated with gender.
(TIF)
S4 Fig. Stability of neutrophil percentage prediction.We tested the stability of our neutro-
phil percentage prediction in the EGCUT dataset (n = 825). From the list of 100 probes show-
ing highest correlation with neutrophil percentage, we randomly selected a number of probes
(increments of 5 probes, 1000 permutations per increment) and repeated the neutrophil per-
centage prediction. When including> 10 probes, the neutrophil prediction displays stable cor-
relation with the actual neutrophil percentage (Spearman R ~0.75) and near perfect correlation
with the predicted neutrophil percentage used in the meta-analysis (Spearman R ~0.99). Error
bars denote standard deviation. Red line denotes the number of gene expression probes the dif-
ferent cohorts in this study used to estimate neutrophil percentage.
(TIF)
S5 Fig. Cis-eQTL effect size and cell type specificity. 71% of the cis-eQTLs that were identi-
fied as being cell type specific by our method show an effect size larger than 0.03 in our original
cis-eQTL meta-analysis (Westra et al, 2013), compared to 21% for those that do not have a sig-
nificant interaction effect.
(TIF)
S6 Fig. Comparison of effect sizes and effect direction between datasets. Comparison of in-
teraction effect Z-scores shows a high consistent direction of effect between datasets and with
the meta-analysis for those interaction effects significant at FDR< 0.05.
(TIF)
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S7 Fig. Relationship between NOD2 gene expression levels, age and gender.We correlated
the actual NOD2 gene expression levels with age in the EGCUT dataset (n = 825, normalized
using log2 transformed and quantile normalization, and gene expression levels corrected for 40
principal components) and observed that there is a low, but significant correlation between age
and NOD2 gene expression in the log2 transformed and quantile normalized data (top), which
becomes insignificant when correcting the gene expression data for 40 principal components
(which was used to determine the neutrophil interaction effect; bottom). However, NOD2 gene
expression levels are not significantly associated with gender.
(TIF)
S8 Fig. Effect of robust estimation of standard errors. The interaction model we used does
not take heteroscedasticity into account. Therefore, we determined standard errors using the
'sandwich' package in R, which allows for the estimation of robust standard errors. We ob-
served strong correlation between standard errors, Z-scores and p-values by our model and a
model that applies robust estimation of standard errors in the EGCUT (top) and Fehrmann
datasets (bottom).
(TIF)
S9 Fig. Principal components on gene expression data. Principal component 1 (PC1) and
principal component 2 per study. Samples with a correlation< 0.9 with PC1 (red) were exclud-
ed from analysis.
(TIF)
S10 Fig. Neutrophil percentage and principal component correction. The gene expression
data that was used for the interaction meta-analysis was corrected for up to 40 principal com-
ponents. In order to retain genetic variation in the gene expression data, components that
showed a significant correlation with genotypes were not removed. In the EGCUT dataset
(n = 825), many of these components also strongly correlate with neutrophil percentage (top)
and inferred neutrophil percentage (bottom). The majority of the variation in gene expression
explained by these components (right) was however removed from this dataset.
(TIF)
S1 Table. List of 58 Illumina HT12v3 probes used for calculating the estimated neutrophil
percentage principal component score and their correlation with neutrophil percentage in
the EGCUT dataset (n = 825).
(XLSX)
S2 Table. Summary statistics for the interaction analysis.
(XLSX)
S3 Table. Results of the interaction analysis.
(XLSX)
S4 Table. Summary statistics showing the effect size (correlation coefficient) in each of the
tested replication datasets.
(XLSX)
S5 Table. Results of the neutrophil mediated cis-eQTL disease enrichment analysis.
(XLSX)
S6 Table. We created proxy phenotypes for the 9 axes of variation described by Preininger
et al [28] within the EGCUT (n = 891) and Fehrmann (n = 1,220) cohorts.We then meta-an-
alyzed the interaction terms for these two cohorts and observed that several axes mediate eQTL
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effects. The Z-scores for the interaction effects for axis 5 correlate strongly with the Z-scores
for interaction effects for the neutrophil proxy (R = 0.74).
(XLSX)
S1 Text. Supplementary note.
(DOCX)
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